Fish-Skin Medical Company Completes Funding Round
February 21, 2014 03:30 ET
|
Kerecis
REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND--(Marketwired - Feb 21, 2014) - Kerecis Limited, the emerging tissue-regeneration company, today announced that it has secured US$2 million in series A3...
Kerecis Receives U.S. Patent for Fish-Skin-Based Tissue Regeneration Technology
February 13, 2014 11:57 ET
|
Kerecis
REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND--(Marketwired - Feb 13, 2014) - Kerecis Limited, the emerging leader in tissue-regeneration materials, has been awarded a U.S. patent for the use of...
Does Fish Skin Reduce Scarring From Plastic Surgery?
January 24, 2014 06:30 ET
|
Kerecis
REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND--(Marketwired - Jan 24, 2014) - Kerecis Limited, the emerging leader in tissue-regeneration materials, and the University Hospital of Iceland will...
Global Markets For Specialty Surgical Wound Care Products In 2013
November 05, 2013 10:55 ET
|
Research and Markets
Dublin, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Research and Markets
(http://www.researchandmarkets.com/research/6q2dkj/global_markets)
has announced the addition of the "Global
Markets For...
The Global Advanced Wound Management Market to Grow At A CAGR Of 4.24 Percent over the Period 2012-2016
October 15, 2013 11:55 ET
|
Research and Markets
Dublin, Oct. 15, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/94hd8j/global_advanced)
has announced the addition of the
"Global Advanced Wound Management...
Kerecis Completes Successful Immunology Study
May 03, 2013 03:05 ET
|
Kerecis
DENVER, CO--(Marketwired - May 3, 2013) - Symposium on Advanced Wound Care -- Kerecis today announced that its recent clinical trial found no allergenic reactions to its fish-skin-composed MariGen...
Kerecis Completes US$ 1 Million Series A2 Funding
April 26, 2013 09:00 ET
|
Kerecis
REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND--(Marketwired - Apr 26, 2013) - Kerecis Limited, the emerging tissue-regeneration company, today announced that it has secured US$ 1 million in series A2...
SANUWAVE to Hold Second Quarter 2012 Financial Results Conference Call on Thursday, August 9
August 06, 2012 16:30 ET
|
SANUWAVE Health, Inc.
ALPHARETTA, Ga., Aug. 6, 2012 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV), an emerging regenerative medicine company focused on the development and commercialization of noninvasive,...
Follow-Up Study Demonstrates Safety and Efficacy of Omega3 Wound-Healing Treatment
May 18, 2012 15:33 ET
|
Kerecis
REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND--(Marketwire - May 18, 2012) - Kerecis, the emerging tissue-regeneration company, has successfully completed a 37-patient follow-up study of its MariGen...
Clinical Trial Demonstrates Safety and Efficacy of Wound-Healing Treatment
October 06, 2011 16:29 ET
|
Kerecis
REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND--(Marketwire - Oct 6, 2011) - Kerecis, the emerging tissue-regeneration company, has successfully completed the first human clinical trial of its MariGen...